ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,441,739, issued on Oct. 14, was assigned to LANZHOU UNIVERSITY (Lanzhou, China) and Tencent Technology Co. Ltd. (Shenzhen, China).

"Glucagon receptor antagonist and use thereof" was invented by Qifeng Bai (Shenzhen, China), Tingyang Xu (Shenzhen, China), Liya Feng (Shenzhen, China), Shuo Liu (Shenzhen, China), Junzhou Huang (Shenzhen, China), Huanxiang Liu (Shenzhen, China) and Xiaojun Yao (Shenzhen, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides a compound and use thereof as a glucagon receptor antagonist. The compound includes a compound A, or an isomer, metabolite, prodrug, pharmaceutically acceptable ester, or p...